BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 20, 2010
View Archived Issues
Cancer vaccine CDX-1401 safe and active in ongoing phase I/II trial
Read More
Snapshots: Studies of new antibiotic CB-182804
Read More
Neurocrine Biosciences advances NBI-98854 into phase II testing
Read More
Aastrom obtains FDA fast track status for phase III CLI program
Read More
HIV vaccine ALVAC vCP1521 is safe in infants given birth to by HIV-infected women
Read More
DepoVax-based vaccination leads to tumor regression in vivo
Read More
Helix BioPharma files IND for phase II/III trial of IFN-alpha-2b for low-grade cervical lesions
Read More
Baraclude approved as therapy for chronic hepatitis B in adults with decompensated liver disease
Read More
Bharat Biotech launches H1N1 flu vaccine HNVAC in India
Read More
European orphan drug status for recombinant porcine factor VIII in hemophilia A
Read More
DiaMedica reports final data from DM-99 study in type 1 diabetes
Read More
Prolong Pharma secures funds to support programs in anemia
Read More
EMA recommends approval of CTI's pediatric investigation plan for Pixuvri
Read More
Sepracor changes name to Sunovion Pharmaceuticals
Read More
Two doses of Duromist oral spray show bioequivalence to Viagra tablet
Read More
New phosphodiesterase 7/8 inhibitors identified at sanofi-aventis
Read More
NeurogesX to submit sNDA to FDA for Qutenza patch in HIV-associated neuropathy
Read More
FDA grants fast track status for HPN-100 in urea cycle disorders
Read More
Vertex initiates phase IIa trial of VX-770/VX-809 for cystic fibrosis
Read More
Pathway Therapeutics presents new inhibitors of PI3K isoforms
Read More
Abbott describes novel GSK-3 beta inhibitors
Read More
Merck & Co. claims new diacylglycerol O-acyltransferase 1 inhibitors
Read More
New selective alpha2C-adrenoceptor agonists identified
Read More
Ocrelizumab reduces disease activity in phase II trial in relapsing-remitting MS
Read More
EC grants orphan drug status for S*BIO's SB-1518 in myelofibrosis
Read More